Catalyst Wire Dossier Catalyst Wire Dossier

DOXORUBICIN HYDROCHLORIDE

Doxorubicin hydrochloride · Pfizer Laboratories Div Pfizer Inc
Drug timelines are a Plus or Pro feature.

79 regulatory and trial events tracked for DOXORUBICIN HYDROCHLORIDE, covering 2007-02-14 to 2026-08-04. Get the full timeline:

Most recent: FDA Approved: DOXORUBICIN HYDROCHLORIDE — Supplemental Application (Zydus Lifesciences Limited)

See pricing